COVID-19: Customer Information

Bruker Partners with Customers to Support major new Frontline Response to Combat the COVID-19 Threat

Bruker MicroCT Systems Supporting Quality Control for Refurbished FFP Masks

As companies and organizations across the world look for ways in which they can play their part, either alone or as part of a collaboration, in the effort to tackle the coronavirus pandemic, Bruker is extremely proud that its instruments are being used to ensure quality levels of reprocessed filtering face pieces (FFP) commonly known as facemasks.

詳細はこちら

Bruker-ANPC-COVID-19-2

Bruker partners with ANPC to support major new frontline response to combat the COVID-19 threat

Bruker is proud to partner with Australian National Phenome Centre (ANPC) at Murdoch University to support the work of their researchers into the COVID-19 pandemic threat.

詳細はこちら

pneumonia_banner

Plasma Metabolomics in H1N1 Influenza Pneumonia Diagnosis

Biomarkers may enable early diagnosis and prognosis, as well as help determine response to treatment. One approach for identifying disease biomarkers is metabolomic profiling.

詳細はこちら

csr-banner-chinese

The Role of Metabolomics in Understanding Traditional Chinese Medicines

Pneumonia is the world's leading cause of death in young children and elderly people. It is an infection that inflames the air sacs in one or both lungs, filling the air sacs with fluid and causing a cough, fever, chills, and breathing difficulties.

詳細はこちら

The Combat Against COVID-19: A Global Network Using NMR Technology

The Combat Against COVID-19: A Global Network Using NMR Technology

Bruker is proud to partner with Dr. Harald Schwalbe of the Goethe University in Frankfurt on using NMR to combat COVID-19.

詳細はこちら

News Related to Covid

Plasma Metabolomics Shows Promise in H1N1 Influenza Pneumonia Diagnosis and Prognosis

Influenza remains the predominant viral cause of community-acquired pneumonia (CAP) in adults. The World Health Organization estimates that annual influenza epidemics result in about 3-5 million cases of severe illness and about 250,000 to 500,000 deaths worldwide. Patients aged 65 years or older are at particular risk of death from viral pneumonia.

Metabolomics and Traditional Chinese Medicine in the treatment of viral pneumonia

Traditional Chinese Medicines (TCMs) are widely used throughout the world in the prevention and treatment of viral pneumonia through the belief in their potential to boost the body's resistance to the pneumonia virus and modulate its immune response. Viruses have established sophisticated mechanisms to interact with the immune system.

Bruker is Happy to be a Partner and is Encouraging Scientists to join the the COVID-19 NMR Initiative

The aim of COVID19-NMR is to determine RNA and protein structures of SARS-CoV-2 and to investigate the drugability of those structures by small molecules. Bruker is happy to provide measurement time on high performance NMR systems as well as sample automation with scientists driving COVID-19 research from home.